Science3-year-old reportedly in remission from liver cancer after CAR-T therapy
Beta Briefing says the child's cancer was resistant to chemotherapy and describes the remission after CAR-T therapy targeting GPC3 as durable.
TLDR
Beta Briefing reported on September 18, 2026, that a 3-year-old with chemo-resistant liver cancer was in durable remission after CAR-T therapy targeting GPC3.
Combined views
4
1 Source, first seen 5d ago
3-year-old reportedly in remission from liver cancer after CAR-T therapy
Beta Briefing says the child's cancer was resistant to chemotherapy and describes the remission after CAR-T therapy targeting GPC3 as durable.
TLDR
Beta Briefing reported on September 18, 2026, that a 3-year-old with chemo-resistant liver cancer was in durable remission after CAR-T therapy targeting GPC3.